Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Overcoming recruitment challenges in patients with multiple sclerosis: Results from an Italian survey.
CD62L is not a reliable biomarker for predicting PML risk in natalizumab-treated R-MS patients.
[Anticholinergics do not affect the sexual function in women diagnosed with multiple sclerosis].
Progressive multifocal leukoencephalopathy: Dot-shaped inclusions and virus-host interactions.
Loss of retinal nerve fibre layer axons indicates white but not grey matter damage in early multiple sclerosis.
Wnt and lithium: a common destiny in the therapy of nervous system pathologies?
Occurrence of Psoriatic Arthritis during Interferon Beta 1a Treatment for Multiple Sclerosis.
Tregitope Peptides: The Active Pharmaceutical Ingredient of IVIG?
Biological markers in cerebrospinal fluid for axonal impairment in multiple sclerosis: acetylcholinesterase activity cannot be considered a useful biomarker.
Isolated bilateral horizontal gaze palsy as first manifestation of multiple sclerosis.
Autoimmune Thyroid Disease in the Use of Alemtuzumab for Multiple Sclerosis: A Review.
Simvastatin: Multiple Sclerosis.
Risk evaluation and monitoring in multiple sclerosis therapeutics.
Exploring Physical Activity in Women with Multiple Sclerosis: Associations with Fear of Falling and Underlying Impairments.
The myelin proteolipid plasmolipin, forms oligomers and induces liquid ordered membranes in the Golgi apparatus.
Directed Differentiation of Oligodendrocyte Progenitor Cells From Mouse Induced Pluripotent Stem Cells.
Dissecting molecular cross-talk between Nrf2 and NF-κB response pathways.
Rapid parametric mapping of the longitudinal relaxation time t1 using two-dimensional variable flip angle magnetic resonance imaging at 1.5 tesla, 3 tesla, and 7 tesla.
Sequential activation of microglia and astrocyte cytokine expression precedes increased iba-1 or GFAP immunoreactivity following systemic immune challenge.
Perceptions of using videogames in rehabilitation: a dual perspective of people with multiple sclerosis and physiotherapists.
Effects of whole body vibration on muscle spasticity for people with central nervous system disorders: A systematic review.
Microparticles in multiple sclerosis and clinically isolated syndrome: effect on endothelial barrier function.
Immune System Involvement in the Pathogenesis of JC Virus Induced PML: What is Learned from Studies of Patients with Underlying Diseases and Therapies as Risk Factors.
Interferon beta-related nephropathy and interstitial lung disease: a new association and a long-term warning.
Does GRK-β arrestin machinery work as a "switch on" for GPR17-mediated activation of intracellular signaling pathways?
Pages
« first
‹ previous
…
428
429
430
431
432
433
434
435
436
…
next ›
last »